The cost of multiple sclerosis drugs in the US and the pharmaceutical industry
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The cost of multiple sclerosis drugs in the US and the pharmaceutical industry have?
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry has 263 citations in the OpenAlex counts ScholarIQ stores.
When was The cost of multiple sclerosis drugs in the US and the pharmaceutical industry published?
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry has 2015 year in the ScholarIQ index.
What is the open-access status of The cost of multiple sclerosis drugs in the US and the pharmaceutical industry?
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry has hybrid oa status in the ScholarIQ index.
What is the DOI of The cost of multiple sclerosis drugs in the US and the pharmaceutical industry?
The DOI for The cost of multiple sclerosis drugs in the US and the pharmaceutical industry is on the source record.
What is the PMID of The cost of multiple sclerosis drugs in the US and the pharmaceutical industry?
The PMID for The cost of multiple sclerosis drugs in the US and the pharmaceutical industry is on the source record.
What is the OpenAlex record for The cost of multiple sclerosis drugs in the US and the pharmaceutical industry?
The OpenAlex for The cost of multiple sclerosis drugs in the US and the pharmaceutical industry is on the source record.